Feb 1, 2023· Comment from Association for Accessible Medicines (AAM)· FDA-2022-N-2671-0011
FDA, Please find attached AAM's comments on FDA's Drug Supply Chain Security Act Implementation and Readiness Efforts for 2023 Virtual Public Meeting (FDA-2022-N-2671). Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs, Association for Accessible Medicines (AAM)